F3M:FRA
Tempus AI Inc
€55.16
arrow_upward
+2.99%(+1.60) 1D
Sep 3, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for F3M...
Open
€52.98
High
€55.16
Low
€52.98
Mkt. cap
11.67B
Avg. vol.
805.00
Volume
250.00
52-wk high
€90.00
52-wk low
€35.79
No. of employees
4K
Open
€52.98
High
€55.16
Low
€52.98
Mkt. cap
11.67B
Avg. vol.
805.00
Volume
250.00
52-wk high
€90.00
52-wk low
€35.79
No. of employees
4K
News stories
From web sources and news partners
Stock Titan
·
2 hours ago
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan
Traders Union
·
3 hours ago
What's behind Tempus AI's latest 4.3% stock surge?
Moomoo
·
1 day ago
Cathie Wood's Investment Moves on September 1! Significantly Increased Stake in Rocket Lab, Reduced Holdings in Tempus AI
Kalkine Media
·
1 day ago
Tempus AI Director Nadja West Sells 3,000 Class A Shares Under Rule 10b5-1 Plan
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus AI Inc
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com